Back to Library

Johnson & Johnson

Finding relief: Craig's story with bipolar II depression

Written by
Johnson & Johnson logoJohnson & Johnson
• Published February 10, 2026 • Updated February 10, 2026 Sponsored Content
Finding relief: Craig's story with bipolar II depression

Sponsored by Johnson & Johnson.

Craig struggled with bipolar II depression for years before finding relief. Unfortunately, his story is very common. 

Johnson & Johnson creative content

“In my twenties, I started feeling little bouts of depression. But by my mid-thirties, I felt like I could no longer function day to day or complete basic tasks. It continued to get worse into my forties. That's when I was diagnosed with bipolar II depression.”

- Craig, living with bipolar II depression

Healthcare professionals frequently run into patients like Craig. Bipolar II depression is part of a larger mental health condition known as bipolar disorder. It’s defined by extreme changes in mood and behavior. These mood swings, known as mood episodes, can cause a person to experience lows (bipolar depression) and highs (mania). 

Johnson & Johnson creative content

About 90% of people report severe impairment due to depressive episodes. 

For some, these depressive episodes can be more debilitating than manic episodes and significantly impact their daily lives. Craig's diagnosis of bipolar II depression means he tends to experience longer, potentially more severe, depressive episodes without the bouts of mania. This can make bipolar II depression hard to diagnose as it can be confused with major depressive disorder. 

Johnson & Johnson creative content

Bipolar I vs bipolar II depression: What's the difference?

Bipolar I Depression 

  • While many people may spend most of their time in depression, they also experience at least one manic episode
  • Some people may also experience hypomania, or episodes of a noticeably elevated mood that don't always impact daily functioning

Bipolar II Depression  

  • People tend to experience longer depressive episodes that can be more severe than with bipolar I
  • Having at least one depressive episode and at least one hypomanic episode, without a manic episode

Finding a treatment that works

Craig worked with his healthcare team for years to identify options that might work. It was only after seeing a TV commercial featuring a treatment option for bipolar II depression that he felt a glimmer of hope. He reached out to his psychiatric nurse practitioner, Deborah, to ask about the treatment. Together, they explored whether it was the right fit for him.

Johnson & Johnson creative content

CAPLYTA® (lumateperone) is proven to provide significant relief from depressive symptoms of bipolar disorder in adults at 6 weeks. Deborah thought CAPLYTA might help Craig.

CAPLYTA has Boxed WARNINGS for increased risk of death in elderly people with dementia-related psychosis and increased risk of suicidal thoughts and behaviors in children and young adults. CAPLYTA is not approved for people under 18. See additional Important Safety Information below.Johnson & Johnson creative content

“I often prescribe CAPLYTA as a treatment for my bipolar I and II depression patients. I feel that the combined efficacy and safety along with the convenient dosing strategy makes CAPLYTA an excellent choice.”

- Deborah, psychiatric nurse practitioner
Patient experiences may differ.

Johnson & Johnson creative content

Craig was drawn to CAPLYTA because it was specifically approved to treat his bipolar II depression. He was relieved to learn that movement disorders and weight gain were not common according to the side effect profile. 

CAPLYTA may cause problems with your metabolism including high blood sugar, diabetes, increased fat (cholesterol and triglyceride) levels in your blood and weight gain. Your healthcare provider should check your blood sugar, fat levels and weight before you start and during your treatment with CAPLYTA.

CAPLYTA may cause serious side effects, including uncontrolled body movements (tardive dyskinesia, TD) in your face, tongue, or other body parts. TD may not go away, even if you stop taking CAPLYTA. It may also occur after you stop taking CAPLYTA.

Please see additional Important Safety Information below.

Johnson & Johnson creative content

Seeing a difference

Deborah explained that CAPLYTA was a once-a-day capsule, believed to work by affecting the chemicals in the brain involved in mood. Craig liked that CAPLYTA was a single pill he could take daily with or without food—and without having to build up to the appropriate dose. 

Johnson & Johnson creative content

“The symptom relief I experience with CAPLYTA has changed things for me. I feel lighter. I'm glad that I no longer feel like I have to fear my condition.”

- Craig, living with bipolar II depression
Patient experiences may differ.

Johnson & Johnson creative content

Craig's story shows how important it is to find the right treatment and the hope that it brings to those living with bipolar II depression.

The most common side effects of CAPLYTA include sleepiness, dizziness, nausea, dry mouth, feeling tired, and diarrhea. CAPLYTA can cause sleepiness and trouble concentrating. Until you know how CAPLYTA affects you, do not drive, operate heavy machinery, or do other dangerous activities. These are not all the possible side effects. Please see additional Important Safety Information below.

If you’d like to hear Craig’s full experience or other real patient stories, watch the videos here. 

For more information on bipolar depression and CAPLYTA, visit CAPLYTA.com.

The patient and nurse practitioner in this promotional article are sharing their individual experiences and have been compensated for their time. This promotional resource is brought to you by Johnson & Johnson.

Watch Craig's story with bipolar II depression

IMPORTANT SAFETY INFORMATION

What is the most important information I should know about CAPLYTA®?

  • Medicines like CAPLYTA® can raise the risk of death in elderly people who have lost touch with reality (psychosis) due to confusion and memory loss (dementia). CAPLYTA® is not approved for treating people with dementia-related psychosis.
  • CAPLYTA® and antidepressant medicines increase the risk of suicidal thoughts and actions in people 24 years of age and younger, especially within the first few months of treatment or when the dose is changed. Depression and other serious mental illnesses are the most important causes of suicidal thoughts and actions.
    • Patients and their families or caregivers should watch for new or worsening depression symptoms, especially sudden changes in mood, behaviors, thoughts, or feelings. This is very important when CAPLYTA® or an antidepressant medicine is started or when the dose is changed.
    • Report any changes in these symptoms to your healthcare provider immediately.
      • thoughts about suicide or dying
      • new or worse depression
      • feeling very agitated or restless
      • trouble sleeping
      • acting aggressive, being angry or violent
      • new or worse anxiety
      • suicide attempts
      • an extreme increase in activity and talking (mania)
      • panic attacks
      • new or worse irritability
      • acting on dangerous impulses
      • other unusual changes in behavior or mood
  • Do not take CAPLYTA® if you are allergic to any of its ingredients. Get emergency medical help if you are having an allergic reaction (e.g., rash, itching, hives, swelling of the tongue, lip, face, or throat).

What are the possible side effects of CAPLYTA®?

CAPLYTA® may cause serious side effects, including:

  • Stroke (cerebrovascular problems) in elderly people with dementia-related psychosis that can lead to death.
  • Neuroleptic malignant syndrome (NMS): high fever, confusion, changes in your breathing, heart rate, and blood pressure, stiff muscles, and increased sweating; these may be symptoms of a rare but potentially fatal condition. Contact your healthcare provider or go to the emergency room if you experience signs and symptoms of NMS.
  • Uncontrolled body movements (tardive dyskinesia, TD) in your face, tongue, or other body parts. TD may not go away, even if you stop taking CAPLYTA®. It may also occur after you stop taking CAPLYTA®.
  • Problems with your metabolism including high blood sugar, diabetes, increased fat (cholesterol and triglyceride) levels in your blood and weight gain. Your healthcare provider should check your blood sugar, fat levels, and weight before you start and during your treatment with CAPLYTA®.
    • Extremely high blood sugar levels can lead to coma or death. Call your healthcare provider if you have any of the following symptoms of high blood sugar: feeling very thirsty, hungry, sick to your stomach, needing to urinate more than usual, weak/tired, or confused, or your breath smells fruity.
  • Low white blood cell count. Your healthcare provider may do blood tests during the first few months of treatment with CAPLYTA®.
  • Decreased blood pressure (orthostatic hypotension). You may feel lightheaded, dizzy, or faint when you rise too quickly from a sitting or lying position.
  • Falls. CAPLYTA® may make you sleepy or dizzy, may cause a decrease in your blood pressure when changing position (orthostatic hypotension), and can slow your thinking and motor skills which may lead to falls that can cause broken bones or other injuries.
  • Seizures (convulsions).
  • Sleepiness, drowsiness, feeling tired, difficulty thinking and doing normal activities. Until you know how CAPLYTA® affects you, do not drive, operate heavy machinery, or do other dangerous activities.
  • Problems controlling your body temperature so that you feel too warm. Avoid getting overheated or dehydrated while taking CAPLYTA®.
  • Difficulty swallowing that can cause food or liquid to get into the lungs.
  • The most common side effects of CAPLYTA® include sleepiness, dizziness, nausea, dry mouth, feeling tired, and diarrhea.

These are not all the possible side effects of CAPLYTA®. 

Before taking CAPLYTA®, tell your healthcare provider about all of your medical conditions, including if you: have or have had heart problems or a stroke, high or low blood pressure, diabetes, or high blood sugar, problems with cholesterol, have or have had a low white blood cell count, seizures (convulsions), or kidney or liver problems.

CAPLYTA® may cause fertility problems in females and males. You should notify your healthcare provider if you become pregnant or intend to become pregnant while taking CAPLYTA®. There is a pregnancy registry for females who are exposed to CAPLYTA® during pregnancy. CAPLYTA® may cause abnormal involuntary movements and/or withdrawal symptoms in newborn babies exposed to CAPLYTA® during the third trimester. Talk to your healthcare provider if you breastfeed or are planning to breastfeed as CAPLYTA® passes into breast milk.

Tell your healthcare provider about all the medicines you’re taking. CAPLYTA® may affect the way other medicines work, and other medicines may affect how CAPLYTA® works, causing possible serious side effects. Do not start or stop any medicines while taking CAPLYTA® without talking to your healthcare provider. You are encouraged to report negative side effects of prescription drugs. Contact Intra-Cellular Therapies, Inc. at 1-888-611-4824 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

CAPLYTA® is available in 42 mg, 21 mg, and 10.5 mg capsules.

What is CAPLYTA® (lumateperone)?

CAPLYTA® (lumateperone) is a prescription medicine used in adults to treat depressive episodes associated with bipolar I or bipolar II disorder (bipolar depression) alone or with lithium or valproate. It is not known if CAPLYTA® is safe and effective in children.

US-CAP-2500883

Please see full Prescribing Information, including Boxed WARNINGS, and Medication Guide for CAPLYTA®.

© Johnson & Johnson and its affiliates 2026 

CAPLYTA is a trademark of Johnson & Johnson and its affiliates. 

Third party trademarks listed are the property of their respective owners.

02/26 US-CAP-2600075